HealthDay News — A high proportion of women seem to undergo mammography screening every year, despite recommendations for biennial screening, according to a research letter published online March 25 ...

An observational study identified light-intensity physical activity and Karnofsky Performance Scale as common characteristics in better functional quality of life for patients with pulmonary and ...

The researchers concluded that slower turnaround time for biomarker testing is associated with early non-targeted treatment in patients with ALK +/ EGFR + advanced NSCLC, a practice that is “common,” ...

Researchers sought to determine whether mosunetuzumab would have long-term efficacy in patients with follicular lymphoma.

Pembrolizumab improved progression-free survival, second progression-free survival, and overall survival. Adding pembrolizumab to concurrent chemoradiotherapy (CCRT) can improve survival outcomes in ...

One-third of patients with PSA levels below 0.2 ng/mL after radical prostatectomy have recurrent disease identifiable by PSMA PET. More than one-third of patients with PSA levels less than 0.5 ng/mL ...

Researchers sought to test the performance of a deep learning model system using longitudinal magnetic resonance imaging (MRI) in predicting early recurrence in patients with hepatocellular carcinoma.

Our real-world findings indicate that most patients undergoing multiple lines of therapy experience persistent treatment refractoriness and low response rates,” the researchers wrote.

Data suggest that the United States had the second highest number of mesothelioma cases and the second highest number of deaths from mesothelioma in 2021. These data were published in Lung Cancer. For ...

Results from a meta-analysis suggest patients with resectable dMMR/MSI-H gastric cancer can forgo perioperative chemotherapy.

Cancer drugs conferring low or no therapeutic benefits accounted for $6.7 billion in post-rebate Medicare spending in 2022.

Study reveals Medicaid and private insurance copay rates are similar for adults 50 years and older using portal messaging.